1 research outputs found
Economic Implications of Patient-Related Factors in Diabetes Care
Diabetes mellitus is a chronic disease characterized by high blood sugar levels with
serious complications, particularly if it is not adequately treated. It is increasingly
prevalent and burdensome from both a health and economic standpoint globally,
amounting to hundreds of billions of dollars in expenditure each year [1,2]. Also
increasing are the numbers and types of pharmaceutical interventions being introduced to
treat this disease. Over the next decade, numerous diabetes compounds currently in
development are expected to be commercialized, making it essential for the most robust
and accurate evidence to be available to healthcare decision-makers [3].
Approximately 90% of people with diabetes are diagnosed as Type 2 (T2D), most often
in adulthood [4]. In contrast, Type 1 diabetes (T1D) patients are commonly diagnosed as
juveniles, but live well into adulthood with effective treatment [4]. Consequently, adult
patients with diabetes, namely T2D, are responsible for most of the health and economic
burden of this disease. Therefore, much of the effort to improve outcomes and reduce
costs in diabetes concentrates on this population